News
BOIRON : Activité du troisième trimestre 2017
ACTIVITÉ DU TROISIÈME TRIMESTRE 2017
(Données non auditées)
ACTIVITÉ CUMULÉE À FIN SEPTEMBRE 2017
en milliers d'euros
2016
2017
Var. taux courant 2017/2016
Var. taux constant....
Here's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today
In response to upbeat results released from a phase 2 clinical trial, shares of Corbus Pharmaceuticals (NASDAQ: CRBP), a clinical-stage biotech focused on inflammatory and fibrotic diseases,....
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax
At one point this year, Cara Therapeutics (NASDAQ: CARA) stock was up more than 175%. Most of those gains were given up, though. The stock is now up a little over 30% year to date. But that's....
3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018
Small-cap biotech stocks, or companies with valuations ranging from $300 million to $2 billion, can generate truly astonishing returns on capital in exceptionally short periods of time. Several of....
3 High-Yield Stocks for Conservative Investors
Conservative equates to cautious. We're talking investing here, of course, and not politics. Conservative investors are by nature cautious. There's nothing wrong with that. After all, Warren....
3 High-Yield Stocks for Conservative Investors
Conservative equates to cautious. We're talking investing here, of course, and not politics. Conservative investors are by nature cautious. There's nothing wrong with that. After all, Warren....
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after....
Why Spectrum Pharmaceuticals Stock Jumped Higher Today
Spectrum Pharmaceuticals (NASDAQ: SPPI), a biotech developing treatments for various blood disorders and cancers, saw its shares gain as much as 51.7% today on over 19 times the average volume.....
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Shares of pre-revenue biopharma Ignyta (NASDAQ: RXDX) jumped over 27% Wednesday morning after it announced promising interim results from an ongoing phase 2/3 clinical trial investigating the....
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Shares of pre-revenue biopharma Ignyta (NASDAQ: RXDX) jumped over 27% Wednesday morning after it announced promising interim results from an ongoing phase 2/3 clinical trial investigating the....
Why Endocyte Is Rallying Today
Shares of Endocyte (NASDAQ: ECYT), a clinical-stage biotech focused on cancer, rose as much as 13% in early-morning trading on Tuesday on heavy volume. As of 11:35 p.m. EDT, the stock was up about....
10 Stunning Numbers You Need to Know About Breast Cancer
October is breast cancer awareness month. Of course, for many American families, there's no need for a month to be designated to remember breast cancer. They're more than aware of the disease....
The Most Disappointing Marijuana Stock Plunged Once Again Last Week
The legal-marijuana industry is growing at an incredible pace, which is a big reason why investors seemingly can't get enough of pot stocks. According to Marijuana Business Daily's latest report,....
Trump Cuts Cost-Sharing Subsidies, but It Won't Matter to Insurers
Donald Trump campaigned for president on a platform that includes repealing and replacing the Affordable Care Act, or Obamacare. However, Congress has failed to get a plan to his desk so far,....
What's Powering Johnson & Johnson's Impressive Quarterly Earnings?
Johnson & Johnson (NYSE: JNJ) surprised investors with better-than-hoped-for top-line and bottom-line performance in the third quarter, and that news sent shares soaring on Tuesday. The....
What's Powering Johnson & Johnson's Impressive Quarterly Earnings?
Johnson & Johnson (NYSE: JNJ) surprised investors with better-than-hoped-for top-line and bottom-line performance in the third quarter, and that news sent shares soaring on Tuesday. The....
3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report
Johnson & Johnson (NYSE: JNJ) often kicks things off for the healthcare sector with the release of its quarterly earnings, and once again, the largest healthcare company by market cap....
3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report
Johnson & Johnson (NYSE: JNJ) often kicks things off for the healthcare sector with the release of its quarterly earnings, and once again, the largest healthcare company by market cap....
A Tiny Upstart Takes Aim at Robotic Surgery
Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX) Senhance. Senhance is a....
A Tiny Upstart Takes Aim at Robotic Surgery
Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX) Senhance. Senhance is a....
A Tiny Upstart Takes Aim at Robotic Surgery
Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX) Senhance. Senhance is a....
UnitedHealth Looks Beyond Obamacare for Growth
Healthcare reform has been a priority among lawmakers in Congress, but they've thus far failed in their efforts to get rid of the Affordable Care Act. Health-insurance company UnitedHealth Group....
UnitedHealth Looks Beyond Obamacare for Growth
Healthcare reform has been a priority among lawmakers in Congress, but they've thus far failed in their efforts to get rid of the Affordable Care Act. Health-insurance company UnitedHealth Group....